Boston Scientific wins U.S. approval for atrial fibrillation device
March 13 (Reuters) - Boston Scientific Corp said the U.S. Food and Drug Administration on Friday approved its device to prevent stroke in patients with a dangerous irregular heart rhythm known as...
Read more »